Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Postgrad Med J ; 99(1172): 595-598, 2023 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-37319160

RESUMO

BACKGROUND AND AIMS: Pituitary apoplexy (PA) is a rare neurosurgical emergency, associated with deficiency of one or more pituitary hormones. Few studies have explored the relative outcomes associated with conservative and neurosurgical intervention. METHODS: A retrospective evaluation of all patients with PA reviewed at Morriston Hospital was undertaken and diagnosis was obtained from Morriston database (Leicester Clinical Workstation database) between 1998 and 2019 from clinic letters and discharge summaries. RESULTS: Thirty-nine patients with PA were identified with a mean age of 74.5 years and 20 (51.3%) patients were women. Patients were followed up for a mean±SD 68.1±61.7 months. Twenty-three (59.0%) patients had a known pituitary adenoma. Commoner clinical presentations of PA were ophthalmoplegia or visual field loss. Following PA, 34 (87.2%) patients were noted to have a non-functioning pituitary adenoma (either pre-existing or new), while 5 (12.8%) patients had a pre-existing functional macroadenoma. Neurosurgical intervention was taken in 15 (38.5%) patients of which 3 (20.0%) patients also received radiotherapy, 2 (13.3%) patients had radiotherapy alone and the remainder managed conservatively. External ophthalmoplegia recovered in all cases. Visual loss remained in all cases. One (2.6%) patient with chromophobe adenoma had a significant second episode of PA requiring repeat surgery. CONCLUSION: PA often occurs in patients with undiagnosed adenoma. Hypopituitarism commonly occurred following conservative or surgical treatment. External ophthalmoplegia resolved in all cases, however, visual loss did not recover. Pituitary tumour recurrence and further PA episodes are rare.


Assuntos
Adenoma , Oftalmoplegia , Apoplexia Hipofisária , Neoplasias Hipofisárias , Humanos , Feminino , Idoso , Masculino , Apoplexia Hipofisária/diagnóstico , Apoplexia Hipofisária/terapia , Apoplexia Hipofisária/complicações , Estudos Retrospectivos , Seguimentos , Neoplasias Hipofisárias/diagnóstico por imagem , Neoplasias Hipofisárias/terapia , Recidiva Local de Neoplasia , Transtornos da Visão/etiologia , Adenoma/complicações , Adenoma/cirurgia , Oftalmoplegia/complicações
4.
Fertil Steril ; 96(1): e7-8, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21575947

RESUMO

OBJECTIVE: To report a case of primary gonadal failure due to the chronic abuse of anabolic steroids used for bodybuilding. DESIGN: Case report. SETTING: Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, Wales, United Kingdom. PATIENT(S): A 40-year-old man. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Clinical symptoms, levels of serum T, FSH, and LH. RESULT(S): Primary gonadal failure resulting from anabolic steroid use. CONCLUSION(S): We describe a case of initially secondary gonadal failure resulting from anabolic steroid use with subsequent primary gonadal failure and infertility. This case adds to the current literature and illustrates that the side effects of anabolic steroids can be prolonged and irreversible.


Assuntos
Anabolizantes/efeitos adversos , Hipogonadismo/induzido quimicamente , Hipogonadismo/diagnóstico , Transtornos Relacionados ao Uso de Substâncias/diagnóstico , Adulto , Anabolizantes/sangue , Hormônio do Crescimento/efeitos adversos , Hormônio do Crescimento/sangue , Humanos , Hipogonadismo/sangue , Masculino , Nandrolona/efeitos adversos , Nandrolona/sangue , Esteroides/efeitos adversos , Esteroides/sangue , Transtornos Relacionados ao Uso de Substâncias/sangue , Testosterona/efeitos adversos , Testosterona/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...